You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Positive refractory or relapsed acute myeloid leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Acute Myeloid Leukemia Trial in Valencia (AFM28)

Recruiting
  • Acute Myeloid Leukemia
  • Valencia, Spain
    Hospital Universitari i Politècnic La Fe
Apr 5, 2023

FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

Recruiting
  • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Wuhan, Hubei, China
    Union Hospital, affiliated with TongJi Medical College, HuaZhong
Jun 20, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin
  • +4 more
  • Baltimore, Maryland
  • +1 more
Dec 13, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial in Suzhou (HYML-122)

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Feb 6, 2022

Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Minimal Residual Disease Trial (Venetoclax, Decitabine,

Not yet recruiting
  • Relapsed Acute Myeloid Leukemia
  • +2 more
  • Venetoclax, Decitabine, Azacytidine, Cytarabine
  • (no location specified)
May 4, 2022

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Leukemia Trial in Houston (Brentuximab Vedotin, 5-Azacytidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 7, 2022

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Completed
  • Recurrent Childhood Acute Myeloid Leukemia
  • +13 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Jan 18, 2023

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Peripheral Blood Stem Cell Transplant
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Mar 27, 2023

    Acute Myeloid Leukemia Trial in Suzhou (anti-FLT3 CAR-T)

    Recruiting
    • Acute Myeloid Leukemia
    • anti-FLT3 CAR-T
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 29, 2021

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Leukemia, Myeloid, Acute Trial in United States (CPX-351, Quizartinib)

    Terminated
    Has Results
    • Leukemia, Myeloid, Acute
    • Denver, Colorado
    • +4 more
    May 10, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +7 more
    • Blinatumomab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
    • Cincinnati, Ohio
    • +18 more
    Jan 20, 2023

    Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

    Recruiting
    • Recurrent Acute Leukemia
    • +16 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Fludarabine + Total Marrow Irradiation
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Jun 1, 2022

    Relapsed/Refractory Acute Myeloid Leukemia Trial in Duarte, Palo Alto, Houston (AMG 553)

    Not yet recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia
    • AMG 553
    • Duarte, California
    • +2 more
    Dec 22, 2021

    Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

    Recruiting
    • Leukemia, Acute Myeloid
    • +7 more
    • Denver, Colorado
    • +4 more
    Aug 29, 2022

    Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma Trial in Milwaukee (XmAb18968 - Dose

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • XmAb18968 - Dose level -1
    • +4 more
    • Milwaukee, Wisconsin
      Froedtert Hospital & the Medical College of Wisconsin
    Feb 15, 2022

    Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

    Active, not recruiting
    • Adult Acute Myeloid Leukemia in Remission
    • +12 more
    • Duarte, California
      City of Hope Medical Center
    Feb 17, 2022

    Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 23, 2023